All public logs

Combined display of all available logs of Beacon. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

20:47, 1 December 2023 Francine talk contribs created page Trials (Tartu University Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Tartu University Hospital page '''NCTID''': NCT04241185 '''Title''': Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) '''Study Summary''': This study is designed to assess the antitumor efficacy and safety of pembrolizumab in combination with chemoradiotherapy (CRT) versus CRT a...")
20:45, 1 December 2023 Francine talk contribs created page Trials (North Estonia Medical Centre) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to North Estonia Medical Centre '''NCTID''': NCT02205047 '''Title''': Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma '''Study Summary''': The purpose of this study is to find out whether either trastuzumab or the combination of trastuzumab and pertuzumab with standard chemotherapy shows more activity against gastro-oesophageal aden...")
20:39, 1 December 2023 Francine talk contribs created page Trials (East Tallinn Central Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to East Tallinn Central Hospital Trials page '''NCTID''': NCT05152147 '''Title''': A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers '''Study Summary''': This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better t...")
20:38, 1 December 2023 Francine talk contribs created page Trials (East Tallinn Central Hospital Trials) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to East Tallinn Central Hospital Trials page '''NCTID''': NCT05152147 '''Title''': A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers '''Study Summary''': This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better t...")
20:05, 1 December 2023 Francine talk contribs created page Trials (Helsinki University Hospital Comprehensive Cancer Center) (Created page with "'''NCTID''': NCT04657991 '''Title''': A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma '''Study Summary''': The purpose of this study is to learn about the effects of three study medicines (encorafenib, binimetinib, and pembrolizumab) given together for the treatment of melanoma that: * is advanced or metastatic (spread to other parts of the body); * has a certain type of abnormal...")
19:02, 1 December 2023 Larysse talk contribs created page Data Dictionary: FINRISK (Created page with "Go back to Finland page. {| class="wikitable" ! Variable !! Field Description |- | FR12_2 || Marital status |- | FR02_3 || Education |- | KOULV || Number of years of education |- | K13 || Number of persons in household |- | K14A || Number of persons in household under the age of 7 |- | K14B || Number of persons in household aged between 7 and 16 |- | TULOT || Household incomes |- | AMM || Occupation |- | IKA10 || 10 year age groups |- | IKA || Age =...")
18:06, 30 November 2023 Francine talk contribs created page Trials (Kortrijk Cancer Centre AZ Groeninge) (Created page with "{{forresearchers}} Go back to Kortrijk Cancer Centre AZ Groeninge page Kortrijk Cancer Centre AZ Groeninge Trials")
13:21, 30 November 2023 Victor talk contribs created page Template:Forproviders (Created page with "Category:forproviders")
13:20, 30 November 2023 Victor talk contribs created page Template:Forpolicymakers (Created page with "Category:forpolicymakers")
13:20, 30 November 2023 Victor talk contribs created page Template:Forresearchers (Created page with "Category:forresearchers")
03:26, 30 November 2023 Woloski talk contribs created page Fondazione I.R.C.C.S. Policlinico San Matteo Trials (Created page with "'''NCTID''': NCT05210790 '''Title''': A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera '''Study Summary''': The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV. '''Sponsor''': Protagonist Therapeutics, Inc. '''Intervention''': Placebo '''Start Date''': 2022-04-01 '''Last Updated''': 2023-11-09 '''Number of Patients''': 250...")
03:23, 30 November 2023 Woloski talk contribs created page Istituto Nazionale Tumori Regina Elena & Istituto Dermatologico San Gallicano Trials (Created page with "'''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced terminal stages. Clinical studies and real-world data show that the use of Patient Reported Outcome Measures (PR...")
03:17, 30 November 2023 Woloski talk contribs created page Fondazione Policlinico Universitario Agostino Gemelli IRCCS Trials (Created page with "'''NCTID''': NCT05323656 '''Title''': A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) '''Study Summary''': The primary objective of this study is to compare the change in tumour size per Response Evaluation Criteria in Solid Tumours Version 1.1 (RECIST v1.1) in recurrent or metastatic SCCHN patients treated with setanaxib and pembrolizumab versus patients treated with pl...")
03:14, 30 November 2023 Woloski talk contribs created page IRCCS - Romagna Institute for the Study of Cancer 'Dino Amadori' Trials (Created page with "'''NCTID''': NCT04775290 '''Title''': Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy '''Study Summary''': The study aims to investigate, through serial measurements of some biomarkers, the potential mechanisms through which yoga impacts on QOL and fatigue. '''Sponsor''': Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori '''Intervention''': Yoga lessons '''Start Date''': 2019-08-02...")
03:09, 30 November 2023 Woloski talk contribs created page Sacro Cuore - Don Calabria Hospital Trials (Created page with "'''NCTID''': NCT01940497 '''Title''': A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer '''Study Summary''': This non-randomized, multicenter, open-label study will assess the safety and efficacy of subcutaneously administered trastuzumab in participants with early and locally advanced HER2-positive breast cancer in two seq...")
03:05, 30 November 2023 Woloski talk contribs created page Mediterranean Institute of Oncology Trials (Created page with "'''NCTID''': NCT06008691 '''Title''': A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice '''Study Summary''': This is a prospective, observational cohort study to evaluate the clinical impact of novel Monoclonal AntiBodies (MAB) in B-cell Non-Hodgkin Lymphoma (NHL) in Italian clinical practice. '''Sponsor''': Fondazione Italiana Linfomi - ETS '''Intervention''...")
03:02, 30 November 2023 Woloski talk contribs created page Candiolo Cancer Institute Trials (Created page with "'''NCTID''': NCT04296890 '''Title''': A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression '''Study Summary''': This study is designed to evaluate the efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with platinum-resistant high-grade serous epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer, w...")
02:59, 30 November 2023 Woloski talk contribs created page Ospedale San Raffaele Trials (Created page with "'''NCTID''': NCT02170090 '''Title''': Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer '''Study Summary''': This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation vs. standard of care (observation alone in stage 1 and capecitabine and observation in stage 2) in patients...")
02:55, 30 November 2023 Woloski talk contribs created page IRCCS Centro di Riferimento Oncologico della Basilicata Trials (Created page with "'''NCTID''': NCT03268954 '''Title''': Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) '''Study Summary''': The purpose of this study is to determine whether the combination of pevonedistat and azacitidine improves event-free survival (EFS) when compared with single-agent azaci...")
02:48, 30 November 2023 Woloski talk contribs created page Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico Trials (Created page with "'''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced terminal stages. Clinical studies and real-world data show that the use of Patient Reported Outcome Measures (PR...")
02:09, 30 November 2023 Woloski talk contribs created page Azienda Unità Sanitaria Locale di Reggio Emilia - IRCCS Istituto in Tecnologie Avanzate e Modelli Assistenziali in Oncologia Trials (Created page with "'''NCTID''': NCT05929222 '''Title''': Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi '''Study Summary''': Prospective, multicenter, open label, phase III randomized clinical trial in previously untreated Follicular Lymphoma in early stage. Patients will be randomized to receive Radiotherapy or Radiotherapy plus Obinotuzumab. '''Sponsor''': Fondazione...")
02:05, 30 November 2023 Woloski talk contribs created page Istituto Nazionale Tumori -IRCCS 'Fondazione G.Pascale' Trials (Created page with "'''NCTID''': NCT03771456 '''Title''': Anastomotic Leakage and Enhanced Recovery Pathways After Colorectal Surgery '''Study Summary''': Prospective observational multicenter study on the influence of adherence to enhanced recovery pathways on early outcomes (anastomotic leakage, morbidity, mortality, readmission, reoperation rates and length of postoperative stay) after elective colorectal surgery in Italy. '''Sponsor''': Ospedale C & G Mazzoni '''Intervention...")
02:00, 30 November 2023 Woloski talk contribs created page Humanitas Research Hospital Trials (Created page with "'''NCTID''': NCT04800497 '''Title''': The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC '''Study Summary''': Hepatocellular carcinoma (HCC) recurs in up to 60% of patients who undergo resection. Circulating tumor cells (CTC) have been advocated as promotors of the recurrence. However, their role as prognostic markers in the surgical setting is unclear. The aim of the present study has been to assess the association between CTC fr...")
01:29, 30 November 2023 Woloski talk contribs created page Istituto Oncologico Veneto IRCCS-IOV Trials (Created page with "'''NCTID''': NCT02170090 '''Title''': Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer '''Study Summary''': This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation vs. standard of care (observation alone in stage 1 and capecitabine and observation in stage 2) in patients...")
01:25, 30 November 2023 Woloski talk contribs created page Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano Trials (Created page with "'''NCTID''': NCT05594290 '''Title''': Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery '''Study Summary''': This is a window-of-opportunity study for patients with resectable Merkel Cell Carcinoma. The aim of this study is to test the activity of a course of chemo-immunotherapy followed by surgery in patients with operable Merkel cell carcinoma. Participants will receive one cycle of retifanlimab plus platinum-etoposide chemoth...")
01:22, 30 November 2023 Woloski talk contribs created page European Institute of Oncology Trials (Created page with "'''NCTID''': NCT05554003 '''Title''': Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study '''Study Summary''': Study design and rationale: Neuroendocrine neoplasms (NENs ) represent a heterogeneous group of malignancies, which differ in terms of behavio r and prognosis. Most of t hem are advanced at diagnosis t herefore systemic treatment is proposed. While over the last ye...")
01:18, 30 November 2023 Woloski talk contribs created page IRCCS Ospedale Policlinico San Martino Trials (Created page with "'''NCTID''': NCT05291156 '''Title''': CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy '''Study Summary''': This is a non-profit phase II, randomized clinical study of the combination of avelumab plus cetuximab as rechallenge strategy, compared to cetuximab alone, in pre-treated RAS/BRAF wild type metastatic colorectal cancer patients (according to liquid biopsy at baseline). Patients have been treated in first...")
01:12, 30 November 2023 Woloski talk contribs created page Centro di Riferimento Oncologico di Aviano Trials (Created page with "'''NCTID''': NCT00002903 '''Title''': Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer '''Study Summary''': RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients with recurrent or refractory germ cell cancer. '''Sponsor''': European Organisation for Research and Treatment of Cancer - EORT...")
01:09, 30 November 2023 Woloski talk contribs created page Rijnstate Trials (Created page with "'''NCTID''': NCT00091156 '''Title''': Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer '''Study Summary''': RATIONALE: Gefitinib may stop the growth of tumor cells by blocking the enzymes necessary for their growth. It is not yet known whether giving gefitinib after initial chemotherapy is effective in delaying the recurrence of non-small cell lung cancer. PURPOSE: This randomized phase III trial is studying ge...")
01:07, 30 November 2023 Woloski talk contribs created page Radboudumc Centre for Oncology Trials (Created page with "'''NCTID''': NCT01322490 '''Title''': A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer '''Study Summary''': The purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from metastatic, castrate-resistant prostate cancer. '''Sponsor'''...")
00:51, 30 November 2023 Woloski talk contribs created page Erasmus MC Kanker Instituut Trials (Created page with "'''NCTID''': NCT05208047 '''Title''': (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors '''Study Summary''': This is a Phase 3, open-label, international, multicenter study of CGT9486 in combination with sunitinib. This is a multi-part study that will enroll approximately 426 patients. Part 1 consists of two evaluations: 1) confirming the dose of an updated formulation of CGT9486 to be used in subse...")
00:48, 30 November 2023 Woloski talk contribs created page University Medical Center Groningen Comprehensive Cancer Center Trials (Created page with "'''NCTID''': NCT03719690 '''Title''': Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy '''Study Summary''': An international, multicenter, open-label, 2 cohort, non-comparative, pivotal study evaluating the efficacy of tipifarnib in HRAS mutant HNSCC (AIM-HN). The first cohort will assess the objective response rate (ORR) of tipifarnib in subjects with HNSCC with HRAS mutations. The second study c...")
00:45, 30 November 2023 Woloski talk contribs created page The Maastricht UMC+ Comprehensive Cancer Center Trials (Created page with "'''NCTID''': NCT02968303 '''Title''': Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy '''Study Summary''': Rationale: The combination of ipilimumab and nivolumab induces relatively high response rates and promising response depth in late stage melanoma. Nevertheless, it takes time till responses occur and still a significant number of patients do not benefit from treatment, due to rapid progressive disease or resistanc...")
00:35, 30 November 2023 Woloski talk contribs created page Netherlands Cancer Institute - Antoni van Leeuwenhoek Trials (Created page with "'''NCTID''': NCT04614103 '''Title''': Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer '''Study Summary''': This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung cancer '''Sponsor''': Iovance Biotherapeutics, Inc. '''Intervention''': LN-145 '''Start Date''': 2021-05-07 '''Last Updated''': 2023-10-10 '''Number of Patients''': 170 '...")
00:32, 30 November 2023 Woloski talk contribs created page Uppsala University Hospital Trials (Created page with "'''NCTID''': NCT00036556 '''Title''': Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer '''Study Summary''': This study is being done to evaluate the safety and efficacy of atrasentan in men with non-metastatic hormone-refractory prostate cancer. '''Sponsor''': Abbott '''Intervention''': Atrasentan '''Start Date''': 2001-06 '''Last Updated''': 2007-08-15 '''Number of Patients''': 941 '''Recruitment Status''': COMPLETED '...")
00:30, 30 November 2023 Woloski talk contribs created page Sahlgrenska University Hospital Trials (Created page with "'''NCTID''': NCT03685890 '''Title''': Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion '''Study Summary''': To evaluate safety and the effect of isolated limb perfusion together with nivolumab as a way to increase efficacy and give further insights in early immunological mechanisms. In the first phase Ib part, 20 patients will be enrolled and followed for a minimum of 3 months. An independent data safety...")
00:26, 30 November 2023 Woloski talk contribs created page Skåne University Hospital Cancer Centre Trials (Created page with "'''NCTID''': NCT02730416 '''Title''': Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer '''Study Summary''': This study will evaluate the role of addition of an anti-angiogenic agent (Nintedanib/placebo) to conventional combination chemotherapy as concomitant and maintenance treatment in primary advanced or with first relapse of endometrial cancer. '''Sponsor''': Nordic Society of Gynaecological Oncology - Clinical Trials Unit '''Interventi...")
00:23, 30 November 2023 Woloski talk contribs created page Karolinska Institute and University Hospital Trials (Created page with "'''NCTID''': NCT01360554 '''Title''': ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer '''Study Summary''': This is a multinational, multicenter, randomized,double-blinded, Phase 3 study comparing the efficacy and safety of treatment with PF-00299804 to treatment with erlotinib in patients with advanced non-small cell lung cancer, previously treated with at least one prior regimen. Analyses of pr...")
00:14, 30 November 2023 Woloski talk contribs created page Catalan Institute of Oncology Trials (Created page with "'''NCTID''': NCT02831959 '''Title''': Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). '''Study Summary''': The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NSCLC patients, following stereotactic radiosurgery (SRS) for 1 inoperable brain metastasis or 2-10 brain...")
00:08, 30 November 2023 Woloski talk contribs created page Vall d’Hebron Barcelona Hospital Campus Trials (Created page with "'''NCTID''': NCT00036556 '''Title''': Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer '''Study Summary''': This study is being done to evaluate the safety and efficacy of atrasentan in men with non-metastatic hormone-refractory prostate cancer. '''Sponsor''': Abbott '''Intervention''': Atrasentan '''Start Date''': 2001-06 '''Last Updated''': 2007-08-15 '''Number of Patients''': 941 '''Recruitment Status''': COMPLETED '...")
00:00, 30 November 2023 Woloski talk contribs created page Fundación Instituto Valenciano de Oncología IVO Trials (Created page with "'''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced terminal stages. Clinical studies and real-world data show that the use of Patient Reported Outcome Measures (PR...")
23:34, 29 November 2023 Woloski talk contribs created page Institute of Oncology Ljubljana Trials (Created page with "'''NCTID''': NCT06060990 '''Title''': Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers '''Study Summary''': The aim of the study is to determine the total concentration of selected trace elements (Cu, Zn, Fe), the proportion of free Cu and Cu bound to ceruloplasmin and the isotopic ratio of Cu65/Cu63 in blood serum samples from healthy volunteers and cancer patients using inductively coupled plasma mass spectr...")
17:59, 29 November 2023 Larysse talk contribs created page Data Dictionary: The Medicines Statistics Register (NPR) (Created page with "Go back to Denmark page Source: [https://www.esundhed.dk/Dokumentation?rid=14&tid=63&vid=317] {| class="wikitable" ! Variables !! Field description |- | aref || Reimbursement schemes that cannot be fitted under the other fields (for shipments from pharmacies where other subsidies have been paid) |- | abc || code for the price of the drug relative to the others in the substitution group |- | aip || The pharmacy's purchase price for one pack at the time of valuation...")
13:51, 29 November 2023 Francine talk contribs created page Data Dictionary - National Registry of Childhood Cancer (RNCCR) (Created page with "=== Variables: === *CNP *Name *First name *Date of birth *Age *Sex *County *City *Address *Date of cancer diagnosis *Explication (reason for registering the diagnosis: hospitalization, death, biopsy, etc.) *Date of clinical onset *Date of relapse *Reason for reporting *Registration base (data source) *Tumor location *Topographical code *Laterality '''Histopathological/cytological examination:''' *Behavior *Morphological code *Degree *Cod ICC3 primary *Cod ICC3...")
13:43, 29 November 2023 Francine talk contribs created page Available Data Dictionary - National Registry of Childhood Cancer (RNCCR) (Created page with "=== Available Variables: === *CNP *Name *First name *Date of birth *Age *Sex *County *City *Address *Date of cancer diagnosis *Explication (reason for registering the diagnosis: hospitalization, death, biopsy, etc.) *Date of clinical onset *Date of relapse *Reason for reporting *Registration base (data source) *Tumor location *Topographical code *Laterality '''Histopathological/cytological examination:''' *Behavior *Morphological code *Degree *Cod ICC3 primary *...")
02:26, 29 November 2023 Woloski talk contribs created page Instituto Português de Oncologia de Coimbra Francisco Gentil Trials (Created page with "'''NCTID''': NCT04459715 '''Title''': A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) '''Study Summary''': The primary objective of the study is to demonstrate superior efficacy of Xevinapant (Debio 1143) vs placebo when added to chemoradio...")
02:24, 29 November 2023 Woloski talk contribs created page Instituto Português de Oncologia de Lisboa Francisco Gentil Trials (Created page with "'''NCTID''': NCT04410445 '''Title''': Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence '''Study Summary''': The main purpose of this study is to compare the efficacy of bempegaldesleukin plus nivolumab versus nivolumab in patients with completely resected Stage IIIA/B/C/D, or Stage IV cutaneous melanoma who are at high risk for recurrence....")
02:19, 29 November 2023 Woloski talk contribs created page Instituto Português de Oncologia do Porto Francisco Gentil Trials (Created page with "'''NCTID''': NCT02500043 '''Title''': Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer '''Study Summary''': The purpose of this trial is to compare the effects of TAS-102 and best supportive care (BSC) with Placebo (an inactive drug) and best supportive care on metastatic gastric cancer. '''Sponsor''': Taiho Oncology, Inc. '''Intervention''': TAS-102 '''Start Date''': 2016-02-24 '''Last Updated''': 2021-09-16 '''Number of Pati...")
02:17, 29 November 2023 Woloski talk contribs created page Greater Poland Cancer Centre Trials (Created page with "'''NCTID''': NCT02467907 '''Title''': Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer '''Study Summary''': This study is to assess safety as defined by the frequency and severity of gastrointestinal (GI) perforation/fistula, GI-vaginal fistula and genitourinary (GU) fistula in participants treated with bevacizumab 15 milligrams per kilogram (mg/kg) in combination with paclitaxel...")
02:07, 29 November 2023 Woloski talk contribs created page Maria Sklodowska- Curie National Research Institute of Oncology Trials (Created page with "'''NCTID''': NCT03517137 '''Title''': Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study '''Study Summary''': The main objective of this trial is to assess whether treatment adaptation based on a very early FDG-PET/CT results in improved efficacy while minimizing treatment toxicity in advanced stage Hodgkin Lymphoma (HL) patients treated with brentuximab vedotin (BV)-containing regimens. '''Sponsor''': Europ...")